It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dual-energy X-ray absorptiometry (DXA) is underutilized to measure bone mineral density (BMD) and evaluate fracture risk. We present an automated tool to identify fractures, predict BMD, and evaluate fracture risk using plain radiographs. The tool performance is evaluated on 5164 and 18175 patients with pelvis/lumbar spine radiographs and Hologic DXA. The model is well calibrated with minimal bias in the hip (slope = 0.982, calibration-in-the-large = −0.003) and the lumbar spine BMD (slope = 0.978, calibration-in-the-large = 0.003). The area under the precision-recall curve and accuracy are 0.89 and 91.7% for hip osteoporosis, 0.89 and 86.2% for spine osteoporosis, 0.83 and 95.0% for high 10-year major fracture risk, and 0.96 and 90.0% for high hip fracture risk. The tool classifies 5206 (84.8%) patients with 95% positive or negative predictive value for osteoporosis, compared to 3008 DXA conducted at the same study period. This automated tool may help identify high-risk patients for osteoporosis.
Dual-energy X-ray absorptiometry and the Fracture Risk Assessment Tool are recommended tools for osteoporotic fracture risk evaluation, but are underutilized. Here, the authors present an opportunistic tool to identify fractures, predict bone mineral density and evaluate fracture risk using plain pelvis and lumbar spine radiographs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Chang Gung Memorial Hospital, Division of Rheumatology, Allergy and Immunology, Taoyuan, Taiwan (GRID:grid.413801.f) (ISNI:0000 0001 0711 0593)
2 PAII Inc., Bethesda, USA (GRID:grid.413801.f)
3 Chang Gung Memorial Hospital, Center for Artificial Intelligence in Medicine, Taoyuan, Taiwan (GRID:grid.413801.f) (ISNI:0000 0001 0711 0593)
4 Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China (GRID:grid.464460.4)
5 PAII Inc., Bethesda, USA (GRID:grid.464460.4)
6 Chang Gung University, Kwei-Shan, Department of Medicine, College of Medicine, Taoyuan, Taiwan (GRID:grid.145695.a); Keelung Chang Gung Memorial Hospital, Department of Obstetrics and Gynecology, Osteoporosis Prevention and Treatment Center, Keelung, Taiwan (GRID:grid.454209.e) (ISNI:0000 0004 0639 2551)
7 PAII Inc., Bethesda, USA (GRID:grid.454209.e)
8 Ping An Insurance (Group) Company of China, Ltd., Shenzhen, China (GRID:grid.454209.e)
9 Chang Gung Memorial Hospital, Division of Rheumatology, Allergy and Immunology, Taoyuan, Taiwan (GRID:grid.413801.f) (ISNI:0000 0001 0711 0593); PAII Inc., Bethesda, USA (GRID:grid.413801.f); Chang Gung University, Kwei-Shan, Department of Medicine, College of Medicine, Taoyuan, Taiwan (GRID:grid.145695.a)